Sionna Therapeutics (SION) Free Cash Flow (2024 - 2026)
Sionna Therapeutics (SION) reported Free Cash Flow of -$21.8 million for Q1 2026, down 33.38% on a YoY basis from -$32.8 million in Q1 2025, and down 29.77% sequentially from -$16.8 million in Q4 2025.
Sionna Therapeutics (SION) Free Cash Flow (2024 - 2026) Analysis & Trends
Sionna Therapeutics (SION) has 3 years of Free Cash Flow data on file, last reported at -$21.8 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 33.38% year-over-year to -$21.8 million; the trailing twelve-month figure through Mar 2026 stood at -$72.1 million (down 28.79% YoY), and the FY2025 full-year result was -$66.7 million, down 26.24% from the prior year.
- Free Cash Flow declined to -$21.8 million in Q1 2026, from -$16.8 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$10.1 million in Q2 2024 to a low of -$21.8 million in Q1 2026.
- A 3-year average of -$15.7 million and a median of -$16.4 million in 2025 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 13.39% in 2025, while the deepest fall reached 78.94% in 2025.
- Tracing SION's Free Cash Flow over 3 years: stood at -$11.8 million in 2024, then slumped by 42.53% to -$16.8 million in 2025, then decreased by 29.77% to -$21.8 million in 2026.
- Business Quant data shows SION's Free Cash Flow at -$21.8 million in Q1 2026, -$16.8 million in Q4 2025, and -$15.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Sionna Therapeutics | 1.98 Bn | 1.98 Bn | - | -21.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.84 Mn |
| Mar 31, 2026 | -21.84 Mn |
| Dec 31, 2025 | -16.83 Mn |
| Dec 31, 2025 | -16.83 Mn |
| Sep 30, 2025 | -15.32 Mn |
| Sep 30, 2025 | -15.32 Mn |
| Jun 30, 2025 | -18.15 Mn |
| Jun 30, 2025 | -18.15 Mn |
| Mar 31, 2025 | -16.37 Mn |
| Mar 31, 2025 | -16.37 Mn |
| Dec 31, 2024 | -11.81 Mn |
| Dec 31, 2024 | -11.81 Mn |
| Sep 30, 2024 | -17.69 Mn |
| Sep 30, 2024 | -17.69 Mn |
| Jun 30, 2024 | -10.15 Mn |
| Jun 30, 2024 | -10.15 Mn |
| Mar 31, 2024 | -13.18 Mn |
| Mar 31, 2024 | -13.18 Mn |